ArticleJournal of pharmaceutical health care and sciences2026
Correction: Association between the incidence of infusion-related reactions by obinutuzumab and the dose of corticosteroid as premedication: a multicenter retrospective cohort study.
Tatsuya Ohtsubo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.